Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on the endeavor zotarolimus-eluting coronary stent.
Pinto Slottow
Tina L
TL
Division of Cardiology, Washington Hospital Center, Washington, DC 20010, USA.
Waksman
Ron
R
D002986:Clinical Trials as Topic; D054855:Drug-Eluting Stents; D006331:Heart Diseases / Q000628:therapy; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D010975:Platelet Aggregation Inhibitors; C489443:zotarolimus; D020123:Sirolimus